
Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.

Sarah Green, PharmD, BCPS, BCIDP, AAHIVP is an infectious diseases clinical pharmacy specialist at Emory University Hospital in Atlanta, Georgia.

Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.

Published: November 3rd 2022 | Updated: